Even though Shen Siyuan knew Wu Ting's description of Phase Three was just a concept meant to bluff people, she couldn't help but feel a surge of excitement after reading it.
Then, she couldn't help but smile.
'That little rascal... he really is a genius. Coming up with such a devilishly clever concept—even I was almost taken in by him.'
'And this concept strikes the Jin Pharmaceutical Group right where it counts! An antiviral drug with the potential to cure liver cancer caused by hepatitis B... That's a massive market! It represents astronomical profits.'
'Clever kid. If it were just this Phase Three concept on its own, no one would pay it any mind. But with the tangible results from Phases One and Two, it really builds a sense of anticipation.'
Pharmaceutical companies run many projects simultaneously every year, each one requiring a massive investment in R&D, but ultimately, only one or two ever yield results.
